Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hyung-Gyoo Kang

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Cell Biology International|December 31, 2013
Urothelial differentiation of human amniotic fluid stem cells by urothelium specific conditioned mediumHenry H Kang, Julia J Kang, Hyung-Gyoo Kang, et al.
The Journal of Biological Chemistry|June 25, 2002
Molecular cloning and characterization of chondroitin-4-O-sulfotransferase-3. A novel member of the HNK-1 family of sulfotransferasesHyung-Gyoo Kang, Matthias R Evers, Guoqing Xia, et al.
Biorxiv : the Preprint Server for Biology|January 16, 2026
CD99Targeted Irinotecan Containing Nanoparticles Show Twenty-Fold Greater Anti-Tumor Effect Than Free Irinotecan For Treatment of Ewing SarcomaHyung-Gyoo Kang, Sheetal Mitra, Bryon Upton, et al.
Plos One|October 28, 2009
GLI1 is a central mediator of EWS/FLI1 signaling in Ewing tumorsJay Joo, Laura Christensen, Kegan Warner, et al.
Molecular Cancer Therapeutics|April 29, 2010
Inhibition of the insulin-like growth factor I receptor by epigallocatechin gallate blocks proliferation and induces the death of Ewing tumor cellsHyung-Gyoo Kang, Jasmine M Jenabi, Xian Fang Liu, et al.
Mycobiology|August 20, 2013
Deletion of GBG1/AYR1 Alters Cell Wall Biogenesis in Saccharomyces cerevisiaeKi-Woong Ahn, Sung Woo Kim, Hyung-Gyoo Kang, et al.
Biorxiv : the Preprint Server for Biology|January 23, 2026
Targeted Nanoparticles: an Innovative Modality in the Treatment of CancerHyung-Gyoo Kang, Bryon Upton, Ryan W Holly, et al.
Cancer Research|April 6, 2007
E-cadherin cell-cell adhesion in ewing tumor cells mediates suppression of anoikis through activation of the ErbB4 tyrosine kinaseHyung-Gyoo Kang, Jasmine M Jenabi, Jingsong Zhang, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Cell Biology International|December 31, 2013
Urothelial differentiation of human amniotic fluid stem cells by urothelium specific conditioned mediumHenry H Kang, Julia J Kang, Hyung-Gyoo Kang, et al.
The Journal of Biological Chemistry|June 25, 2002
Molecular cloning and characterization of chondroitin-4-O-sulfotransferase-3. A novel member of the HNK-1 family of sulfotransferasesHyung-Gyoo Kang, Matthias R Evers, Guoqing Xia, et al.
Biorxiv : the Preprint Server for Biology|January 16, 2026
CD99Targeted Irinotecan Containing Nanoparticles Show Twenty-Fold Greater Anti-Tumor Effect Than Free Irinotecan For Treatment of Ewing SarcomaHyung-Gyoo Kang, Sheetal Mitra, Bryon Upton, et al.
Plos One|October 28, 2009
GLI1 is a central mediator of EWS/FLI1 signaling in Ewing tumorsJay Joo, Laura Christensen, Kegan Warner, et al.
Molecular Cancer Therapeutics|April 29, 2010
Inhibition of the insulin-like growth factor I receptor by epigallocatechin gallate blocks proliferation and induces the death of Ewing tumor cellsHyung-Gyoo Kang, Jasmine M Jenabi, Xian Fang Liu, et al.
Mycobiology|August 20, 2013
Deletion of GBG1/AYR1 Alters Cell Wall Biogenesis in Saccharomyces cerevisiaeKi-Woong Ahn, Sung Woo Kim, Hyung-Gyoo Kang, et al.
Biorxiv : the Preprint Server for Biology|January 23, 2026
Targeted Nanoparticles: an Innovative Modality in the Treatment of CancerHyung-Gyoo Kang, Bryon Upton, Ryan W Holly, et al.
Cancer Research|April 6, 2007
E-cadherin cell-cell adhesion in ewing tumor cells mediates suppression of anoikis through activation of the ErbB4 tyrosine kinaseHyung-Gyoo Kang, Jasmine M Jenabi, Jingsong Zhang, et al.
Pageof 1